Ahmet Dirican: “Time-of-day Immunotherapy” Should Remain Hypothesis-Generating, Not Practice-Changing

Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:

“The effect size is striking. The editor’s note is concerning. Until inconsistencies are clarified, “time-of-day immunotherapy” should remain hypothesis-generating — not practice-changing.”